Appili Therapeutics (APLIF) Short Interest Ratio & Short Volume → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free APLIF Stock Alerts $0.03 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Appili Therapeutics Short Interest DataCurrent Short Volume37,400 sharesPrevious Short Volume124,200 sharesChange Vs. Previous Month-69.89%Dollar Volume Sold Short$942.48Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares121,270,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume0 sharesAverage Trading Volume448,459 sharesToday's Volume Vs. Average0% Short Selling Appili Therapeutics ? Sign up to receive the latest short interest report for Appili Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPLIF Short Interest Over TimeAPLIF Days to Cover Over TimeAPLIF Percentage of Float Shorted Over Time Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Appili Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202437,400 shares $942.48 -69.9%N/A0 $0.03 3/31/2024124,200 shares $2,657.88 +42.9%N/A7.2 $0.02 3/15/202486,900 shares $1,929.18 +16.5%N/A0.3 $0.02 2/29/202474,600 shares $1,618.82 +106.1%N/A0.1 $0.02 2/15/202436,200 shares $807.26 -5.0%N/A0.2 $0.02 1/15/202439,300 shares $884.25 -4.8%N/A0.1 $0.02 Get the Latest News and Ratings for APLIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202341,300 shares $1,094.45 -2.1%N/A0.6 $0.03 12/15/202342,200 shares $1,055.00 -2.3%N/A1.3 $0.03 11/30/202343,200 shares $1,028.16 -47.4%N/A0.3 $0.02 11/15/202382,100 shares $1,814.41 +81.6%N/A1.1 $0.02 10/31/202345,200 shares $1,301.76 -35.8%N/A0.4 $0.03 10/15/202370,400 shares $2,112.00 +4.1%N/A0.2 $0.03 9/30/202367,600 shares $2,804.05 +37.4%N/A0 $0.04 9/15/202349,200 shares $1,968.00 No ChangeN/A0.3 $0.04 8/31/202349,200 shares $1,972.92 -53.7%N/A0.2 $0.04 8/15/2023106,200 shares $3,823.20 -33.8%N/A0.2 $0.04 7/31/2023160,400 shares $7,185.92 +226.0%N/A0.1 $0.04 7/15/202349,200 shares $1,520.28 -22.2%N/A0.1 $0.03 6/30/202363,200 shares $1,390.40 +14.5%N/A0.5 $0.02 6/15/202355,200 shares $1,269.60 +10.0%N/A2.7 $0.02 5/31/202350,200 shares $1,417.65 -3.3%N/A3.3 $0.03 5/15/202351,900 shares $1,385.73 +1.4%N/A0.8 $0.03 4/30/202351,200 shares $1,505.28 No ChangeN/A1 $0.03 4/15/202351,200 shares $1,315.84 No ChangeN/A13.8 $0.03 3/31/202351,200 shares $1,295.36 No ChangeN/A0.5 $0.03 3/15/202351,200 shares $1,720.32 -4.5%N/A7.9 $0.03 2/28/202353,600 shares $1,817.04 +4.7%N/A5.7 $0.03 2/15/202351,200 shares $4,096.00 -1.9%N/A0.9 $0.08 1/31/202352,200 shares $2,124.54 No ChangeN/A1.9 $0.04 1/15/202352,200 shares $2,453.40 -13.9%N/A3.5 $0.05 12/30/202260,600 shares $2,187.66 -10.2%N/A0.7 $0.04 12/15/202267,500 shares $3,003.75 +12.1%N/A1.6 $0.04 11/30/202260,200 shares $2,100.98 -10.4%N/A7.3 $0.03 11/15/202267,200 shares $2,197.44 -6.9%N/A2.4 $0.03 10/31/202272,200 shares $3,046.84 -5.3%N/A14.7 $0.04 10/15/202276,200 shares $2,739.39 -1.3%N/A8.9 $0.04 9/30/202277,200 shares $3,010.80 -1.3%N/A0.9 $0.04 9/15/202278,200 shares $3,503.36 -33.2%N/A1.7 $0.04 8/31/2022117,100 shares $5,491.99 -17.0%N/A8.9 $0.05 8/15/2022141,100 shares $8,697.40 +7.1%N/A13.7 $0.06World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. APLIF Short Interest - Frequently Asked Questions What is Appili Therapeutics' current short interest? Short interest is the volume of Appili Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 37,400 shares of APLIF short. Learn More on Appili Therapeutics' current short interest. Is Appili Therapeutics' short interest increasing or decreasing? Appili Therapeutics saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 37,400 shares, a drop of 69.9% from the previous total of 124,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Appili Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Appili Therapeutics: GeoVax Labs, Inc. (0.28%), Vivesto AB (0.00%), NexImmune, Inc. (0.89%), Mustang Bio, Inc. (1.84%), Evoke Pharma, Inc. (0.54%), Atreca, Inc. (0.37%), 60 Degrees Pharmaceuticals, Inc. (1.50%), Phio Pharmaceuticals Corp. (0.75%), Cingulate Inc. (0.58%), Virpax Pharmaceuticals, Inc. (1.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Appili Therapeutics stock? Short selling APLIF is an investing strategy that aims to generate trading profit from Appili Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Appili Therapeutics? A short squeeze for Appili Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APLIF, which in turn drives the price of the stock up even further. How often is Appili Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLIF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: GOVX Short Squeeze OASMY Short Squeeze NEXI Short Squeeze MBIO Short Squeeze EVOK Short Squeeze BCEL Short Squeeze SXTP Short Squeeze PHIO Short Squeeze CING Short Squeeze VRPX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:APLIF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative